SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001493152-23-016590
Filing Date
2023-05-12
Accepted
2023-05-12 14:55:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 85673
  Complete submission text file 0001493152-23-016590.txt   87134
Mailing Address C/O SEELOS THERAPEUTICS, INC. 300 PARK AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address
O'Connor Daniel J. (Filed by) CIK: 0001376847 (see all company filings)

Type: SC 13D/A

Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Subject) CIK: 0001859007 (see all company filings)

IRS No.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-93211 | Film No.: 23915069
SIC: 2834 Pharmaceutical Preparations